These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16274644)

  • 1. [Predictive testing: presymptomatic diagnosis in neurogenetic disorders].
    Dürr A; Gargiulo M; Feingold J
    Med Sci (Paris); 2005 Nov; 21(11):934-9. PubMed ID: 16274644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Huntington disease: presymptomatic testing, prenatal diagnosis, preimplantation genetic diagnosis experience].
    Durr A; Viville S
    Gynecol Obstet Fertil; 2007 Oct; 35(10):1051-4. PubMed ID: 17897866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity of judgement in decision making for predictive testing for nontreatable adult-onset neurogenetic conditions: a case against predictive testing of minors.
    Richards FH
    Clin Genet; 2006 Nov; 70(5):396-401. PubMed ID: 17026621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presymptomatic testing for Huntington's disease. Emotional aspects.
    Zak JP; Zaglul JT; Mueller OT; Diamond T
    J Fla Med Assoc; 1994 Feb; 81(2):109-12. PubMed ID: 8169585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease].
    Jakobsen LB; Malt U; Nilsson B; Rosenlund S; Heiberg A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1913-6. PubMed ID: 10382341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan.
    Markel DS; Young AB; Penney JB
    Am J Med Genet; 1987 Feb; 26(2):295-305. PubMed ID: 2949613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
    Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic DNA testing for Huntington disease].
    Helle JR; Braathen GJ; Skodje T; Berg K
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2408-10. PubMed ID: 11475226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early testing for Huntington disease in children: pros and cons.
    Toufexis M; Gieron-Korthals M
    J Child Neurol; 2010 Apr; 25(4):482-4. PubMed ID: 19808987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of German persons at risk for Huntington's disease toward predictive and prenatal testing.
    Kreuz FR
    Genet Couns; 1996; 7(4):303-11. PubMed ID: 8985735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial effects of predictive testing for Huntington's disease.
    Hayden MR; Bombard Y
    Adv Neurol; 2005; 96():226-39. PubMed ID: 16383222
    [No Abstract]   [Full Text] [Related]  

  • 13. Intended use of predictive testing by those at risk for Huntington disease.
    Meissen GJ; Berchek RL
    Am J Med Genet; 1987 Feb; 26(2):283-93. PubMed ID: 2949612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic counseling in presymptomatic testing for Huntington disease].
    Helle JR; Braathen GJ; Pedersen JC; Skodje T; Stokke B; Berg K
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2412-6. PubMed ID: 11475227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.
    Bloch M; Adam S; Fuller A; Kremer B; Welch JP; Wiggins S; Whyte P; Huggins M; Theilmann J; Hayden MR
    Am J Med Genet; 1993 Sep; 47(3):368-74. PubMed ID: 8135283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
    Tibben A; Frets PG; van de Kamp JJ; Niermeijer MF; Vegtervan der Vlis M; Roos RA; Rooymans HG; van Ommen GJ; Verhage F
    Am J Med Genet; 1993 Jul; 48(2):103-11. PubMed ID: 8362926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes toward presymptomatic testing in Huntington disease.
    Mastromauro C; Myers RH; Berkman B
    Am J Med Genet; 1987 Feb; 26(2):271-82. PubMed ID: 2949611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychosocial aspects in presymptomatic testing for genetic diseases. Experiences after 2 years of counseling in Huntington disease].
    Blomhoff S; Malt U; Weisaeth L
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):27-9. PubMed ID: 7846655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington's disease.
    Craufurd D
    Prenat Diagn; 1996 Dec; 16(13):1237-45. PubMed ID: 9061754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Huntington's disease: ethical aspects of presymptomatic testing].
    Gelman-Kohan Z; Chemke J; Nisani R
    Harefuah; 1993 Feb; 124(4):196-8, 247. PubMed ID: 8495897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.